Clinical characterization of data-driven diabetes subgroups in Mexicans using a reproducible machine learning approach

Omar Yaxmehen Bello-Chavolla, Jessica Paola Bahena-López, Arsenio Vargas-Vázquez, Neftali Eduardo Antonio-Villa, Alejandro Márquez-Salinas, Carlos A Fermín-Martínez, Rosalba Rojas, Roopa Mehta, Ivette Cruz-Bautista, Sergio Hernández-Jiménez, Ana Cristina García-Ulloa, Paloma Almeda-Valdes, Carlos Alberto Aguilar-Salinas, Metabolic Syndrome Study Group, Group of Study CAIPaDi, Olimpia Arellano-Campos, Donaji V Gómez-Velasco, Omar Yaxmehen Bello-Chavolla, César Lam-Chung, Ivette Cruz-Bautista, Marco A Melgarejo-Hernandez, Paloma Almeda-Valdés, Alexandro J Martagón, Liliana Muñoz-Hernandez, Luz E Guillén, José de Jesús Garduño-García, Ulices Alvirde, Yukiko Ono-Yoshikawa, Ricardo Choza-Romero, Leobardo Sauque-Reyna, Ma Eugenia Garay-Sevilla, Juan M Malacara-Hernandez, María Teresa Tusié-Luna, Luis Miguel Gutierrez-Robledo, Francisco J Gómez-Pérez, Rosalba Rojas, Carlos A Aguilar-Salinas, Sergio Hernández-Jiménez, Cristina García-Ulloa, Eder Patiño-Rivera, Denise Arcila-Martínez, Rodrigo Arizmendi-Rodríguez, Oswaldo Briseño-González, Humberto Del Valle-Ramírez, Arturo Flores-García, Fernanda Garnica-Carrillo, Eduardo González-Flores, Mariana Granados-Arcos, Héctor Infanzón-Talango, Victoria Landa-Anell, Claudia Lechuga-Fonseca, Arely López-Reyes, Marco Melgarejo-Hernández, Palacios-Vargas Angélica, Liliana Pérez-Peralta, Alberto Ramírez-García, David Rivera de la Parra, Sofía Ríos-Villavicencio, Francis Rojas-Torres, Marcela Ruiz-Cervantes, Sandra Sainos-Muñoz, Alejandra Sierra-Esquivel, Erendi Tinoco-Ventura, Luz Elena Urbina-Arronte, María Luisa Velasco-Pérez, Héctor Velázquez-Jurado, Andrea Villegas-Narváez, Verónica Zurita-Cortés, Enrique Graue-Hernández Aída Jiménez-Corona, Carlos A Aguilar-Salinas, Francisco J Gómez-Pérez, David Kershenobich-Stalnikowitz, Omar Yaxmehen Bello-Chavolla, Jessica Paola Bahena-López, Arsenio Vargas-Vázquez, Neftali Eduardo Antonio-Villa, Alejandro Márquez-Salinas, Carlos A Fermín-Martínez, Rosalba Rojas, Roopa Mehta, Ivette Cruz-Bautista, Sergio Hernández-Jiménez, Ana Cristina García-Ulloa, Paloma Almeda-Valdes, Carlos Alberto Aguilar-Salinas, Metabolic Syndrome Study Group, Group of Study CAIPaDi, Olimpia Arellano-Campos, Donaji V Gómez-Velasco, Omar Yaxmehen Bello-Chavolla, César Lam-Chung, Ivette Cruz-Bautista, Marco A Melgarejo-Hernandez, Paloma Almeda-Valdés, Alexandro J Martagón, Liliana Muñoz-Hernandez, Luz E Guillén, José de Jesús Garduño-García, Ulices Alvirde, Yukiko Ono-Yoshikawa, Ricardo Choza-Romero, Leobardo Sauque-Reyna, Ma Eugenia Garay-Sevilla, Juan M Malacara-Hernandez, María Teresa Tusié-Luna, Luis Miguel Gutierrez-Robledo, Francisco J Gómez-Pérez, Rosalba Rojas, Carlos A Aguilar-Salinas, Sergio Hernández-Jiménez, Cristina García-Ulloa, Eder Patiño-Rivera, Denise Arcila-Martínez, Rodrigo Arizmendi-Rodríguez, Oswaldo Briseño-González, Humberto Del Valle-Ramírez, Arturo Flores-García, Fernanda Garnica-Carrillo, Eduardo González-Flores, Mariana Granados-Arcos, Héctor Infanzón-Talango, Victoria Landa-Anell, Claudia Lechuga-Fonseca, Arely López-Reyes, Marco Melgarejo-Hernández, Palacios-Vargas Angélica, Liliana Pérez-Peralta, Alberto Ramírez-García, David Rivera de la Parra, Sofía Ríos-Villavicencio, Francis Rojas-Torres, Marcela Ruiz-Cervantes, Sandra Sainos-Muñoz, Alejandra Sierra-Esquivel, Erendi Tinoco-Ventura, Luz Elena Urbina-Arronte, María Luisa Velasco-Pérez, Héctor Velázquez-Jurado, Andrea Villegas-Narváez, Verónica Zurita-Cortés, Enrique Graue-Hernández Aída Jiménez-Corona, Carlos A Aguilar-Salinas, Francisco J Gómez-Pérez, David Kershenobich-Stalnikowitz

Abstract

Introduction: Previous reports in European populations demonstrated the existence of five data-driven adult-onset diabetes subgroups. Here, we use self-normalizing neural networks (SNNN) to improve reproducibility of these data-driven diabetes subgroups in Mexican cohorts to extend its application to more diverse settings.

Research design and methods: We trained SNNN and compared it with k-means clustering to classify diabetes subgroups in a multiethnic and representative population-based National Health and Nutrition Examination Survey (NHANES) datasets with all available measures (training sample: NHANES-III, n=1132; validation sample: NHANES 1999-2006, n=626). SNNN models were then applied to four Mexican cohorts (SIGMA-UIEM, n=1521; Metabolic Syndrome cohort, n=6144; ENSANUT 2016, n=614 and CAIPaDi, n=1608) to characterize diabetes subgroups in Mexicans according to treatment response, risk for chronic complications and risk factors for the incidence of each subgroup.

Results: SNNN yielded four reproducible clinical profiles (obesity related, insulin deficient, insulin resistant, age related) in NHANES and Mexican cohorts even without C-peptide measurements. We observed in a population-based survey a high prevalence of the insulin-deficient form (41.25%, 95% CI 41.02% to 41.48%), followed by obesity-related (33.60%, 95% CI 33.40% to 33.79%), age-related (14.72%, 95% CI 14.63% to 14.82%) and severe insulin-resistant groups. A significant association was found between the SLC16A11 diabetes risk variant and the obesity-related subgroup (OR 1.42, 95% CI 1.10 to 1.83, p=0.008). Among incident cases, we observed a greater incidence of mild obesity-related diabetes (n=149, 45.0%). In a diabetes outpatient clinic cohort, we observed increased 1-year risk (HR 1.59, 95% CI 1.01 to 2.51) and 2-year risk (HR 1.94, 95% CI 1.13 to 3.31) for incident retinopathy in the insulin-deficient group and decreased 2-year diabetic retinopathy risk for the obesity-related subgroup (HR 0.49, 95% CI 0.27 to 0.89).

Conclusions: Diabetes subgroup phenotypes are reproducible using SNNN; our algorithm is available as web-based tool. Application of these models allowed for better characterization of diabetes subgroups and risk factors in Mexicans that could have clinical applications.

Keywords: ethnic groups; insulin resistance; statistical models; type 2 diabetes mellitus.

Conflict of interest statement

Competing interests: JPB-L, AV-V and NEA-V are enrolled at the PECEM program of the Faculty of Medicine at UNAM. JPB-L and AV-V are supported by CONACyT.

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
(A) Diabetes subgroup distribution in NHANES III used for model training, NHANES 1999–2004 used for model validation and ENSANUT 2016 used for model testing, demonstrating relevant differences in diabetes distribution. (B) Distribution of type 2 diabetes clusters according to ADO, HOMA2-β, HOMA2-IR, BMI, HbA1c and fasting plasma glucose in the combined NHANES cohorts. ADO, age at diabetes onset; BMI, body mass index; HbA1c, glycated hemoglobin; HOMA, homeostasis model assessment; IR, insulin resistance; MARD, mild age-related diabetes; MOD, mild obesity-related diabetes; NHANES, National Health and Nutrition Examination Survey; SIDD, severe insulin-deficient diabetes; SIRD, severe insulin-resistant diabetes.
Figure 2
Figure 2
Sankey plot of transitions of diabetes subtypes after 3 months (A, n=1680), 1 year (B, n=852) and 2 years (C, n=476) of an intensive multidisciplinary intervention with variables collected at baseline and after 3 months, 1 and 2 years of follow-up. MARD, mild age-related diabetes; MOD, mild obesity-related diabetes; SIDD, severe insulin-deficient diabetes; SIRD, severe insulin-resistant diabetes.

References

    1. Ahlqvist E, Storm P, Käräjämäki A, et al. . Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol 2018;6:361–9. 10.1016/S2213-8587(18)30051-2
    1. Zaharia OP, Strassburger K, Strom A, et al. . Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. Lancet Diabetes Endocrinol 2019;7:S2213-8587(19)30187-1:684–94. 10.1016/S2213-8587(19)30187-1
    1. Ferrannini E, Gastaldelli A, Matsuda M, et al. . Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis. J Clin Endocrinol Metab 2003;88:3251–7. 10.1210/jc.2002-021864
    1. Agbim U, Carr RM, Pickett-Blakely O, et al. . Ethnic disparities in adiposity: focus on non-alcoholic fatty liver disease, visceral, and generalized obesity. Curr Obes Rep 2019;8:243–54. 10.1007/s13679-019-00349-x
    1. Bancks MP, Casanova R, Gregg EW, et al. . Epidemiology of diabetes phenotypes and prevalent cardiovascular risk factors and diabetes complications in the National Health and Nutrition Examination Survey 2003-2014. Diabetes Res Clin Pract 2019;158:107915. 10.1016/j.diabres.2019.107915
    1. Udler MS, Kim J, von Grotthuss M, et al. . Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: a soft clustering analysis. PLoS Med 2018;15:e1002654. 10.1371/journal.pmed.1002654
    1. Steinley D. Stability analysis in k-means clustering. Br J Math Stat Psychol 2008;61:255–73. 10.1348/000711007X184849
    1. Lisboa PJG, Etchells TA, Jarman IH, et al. . Finding reproducible cluster partitions for the k-means algorithm. BMC Bioinformatics 2013;14(Suppl 1):S8. 10.1186/1471-2105-14-S1-S8
    1. Meilă M. Comparing clusterings—an information based distance. J Multivar Anal 2007;98:873–95. 10.1016/j.jmva.2006.11.013
    1. Klambauer G, Unterthiner T, Mayr A, et al. . Self-Normalizing neural networks. arXiv. 1706.02515v5 [cs.LG].
    1. Dennis JM, Shields BM, Henley WE, et al. . Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data. Lancet Diabetes Endocrinol 2019;7:442–51. 10.1016/S2213-8587(19)30087-7
    1. Zou X, Zhou X, Zhu Z, et al. . Novel subgroups of patients with adult-onset diabetes in Chinese and US populations. Lancet Diabetes Endocrinol 2019;7:9–11. 10.1016/S2213-8587(18)30316-4
    1. Bello-Chavolla OY, Antonio-Villa NE, Vargas-Vázquez A, et al. . Metabolic score for visceral fat (METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic health. Clin Nutr 2020;39:S0261-5614(19)30294-8. 10.1016/j.clnu.2019.07.012
    1. Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, et al. . METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol 2018;178:533–44. 10.1530/EJE-17-0883
    1. Arellano-Campos O, Gómez-Velasco DV, Bello-Chavolla OY, et al. . Development and validation of a predictive model for incident type 2 diabetes in middle-aged Mexican adults: the metabolic syndrome cohort. BMC Endocr Disord 2019;19:41. 10.1186/s12902-019-0361-8
    1. Basto-Abreu A, Barrientos-Gutiérrez T, Rojas-Martínez R, et al. . [Prevalence of diabetes and poor glycemic control in Mexico: results from Ensanut 2016.]. Salud Publica Mex 2020;62:50–9. 10.21149/10752
    1. Bedogni G, Bellentani S, Miglioli L, et al. . The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006;6:33. 10.1186/1471-230X-6-33
    1. SIGMA Type 2 Diabetes Consortium, Williams AL, Jacobs SBR, et al. . Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. Nature 2014;506:97–101. 10.1038/nature12828
    1. Almeda-Valdes P, Gómez Velasco DV, Arellano Campos O, et al. . The SLC16A11 risk haplotype is associated with decreased insulin action, higher transaminases and large-size adipocytes. Eur J Endocrinol 2019;180:99–107. 10.1530/EJE-18-0677
    1. Hernández-Jiménez S, García-Ulloa AC, Bello-Chavolla OY, et al. . Long-Term effectiveness of a type 2 diabetes comprehensive care program. The CAIPaDi model. Diabetes Res Clin Pract 2019;151:128–37. 10.1016/j.diabres.2019.04.009
    1. Gubbi S, Hamet P, Tremblay J, et al. . Artificial intelligence and machine learning in endocrinology and metabolism: the dawn of a new era. Front Endocrinol 2019;10:185. 10.3389/fendo.2019.00185
    1. Bello-Chavolla OY, Rojas-Martinez R, Aguilar-Salinas CA, et al. . Epidemiology of diabetes mellitus in Mexico. Nutr Rev 2017;75:4–12. 10.1093/nutrit/nuw030
    1. Herrington WG, Alegre-Díaz J, Wade R, et al. . Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort study. Lancet Diabetes Endocrinol 2018;6:455–63. 10.1016/S2213-8587(18)30050-0
    1. Shyr ZA, Wang Z, York NW, et al. . The role of membrane excitability in pancreatic β-cell glucotoxicity. Sci Rep 2019;9:6952. 10.1038/s41598-019-43452-8
    1. Zimmet PZ, Tuomi T, Mackay IR, et al. . Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 1994;11:299–303. 10.1111/j.1464-5491.1994.tb00275.x
    1. Delitala AP, Pes GM, Fanciulli G, et al. . Organ-specific antibodies in LADA patients for the prediction of insulin dependence. Endocr Res 2016;41:207–12. 10.3109/07435800.2015.1136934
    1. Segovia-Gamboa NC, Rodríguez-Arellano ME, Muñoz-Solís A, et al. . High prevalence of humoral autoimmunity in first-degree relatives of Mexican type 1 diabetes patients. Acta Diabetol 2018;55:1275–82. 10.1007/s00592-018-1241-9

Source: PubMed

Подписаться